High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

The AIDS Clinical Trials Group and the Tuberculosis Trials Consortium

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences